NEWS

CERENOVUS Launches New Suite of Technologies to Advance Stroke Treatment

IRVINE, CA – September 9, 2020 – CERENOVUS, part of Johnson & Johnson Medical Devices Companies* today announced that it has launched CERENOVUS Stroke Solutions™, which includes a suite of three devices designed to aid physicians in clot removal procedures. The announcement was made during the virtual European Society of Minimally Invasive Neurological Therapy (ESMINT).

Giant serpentine aneurysm with difficult anatomy

Right MCA aneurysm treated with balloon-assisted WEB

Wallaby Medical Raises over $20M in Series B+ Financing to Accelerate De...

The new funding will promote the development of a global hemorrhagic and ischemic stroke treatment product portfolio, as well as support the company’s two ongoing clinical trials.

Treating a right ICA aneurysm using an EVOLVE flow diverter

An unusual case of stroke

Cerus Endovascular and Balt Enter Strategic Distribution Agreement for I...

FREMONT, Calif. and OXFORD, United Kingdom and MONTMORENCY, France, Cerus Endovascular Ltd., a privately-held, commercial-stage medical device company and AB Medica Deutschland Verwaltungs GmbH, a wholly owned subsidiary of Balt, today announced that they have entered into a strategic distribution agreement providing AB Medica with the exclusive rights to market and sell the newly CE marked Contour Neurovascular System™ and the Neqstent Coil Assisted Flow Diverter devices in Germany. Terms of the agreement were not disclosed.

Cerus Endovascular Receives CE Mark Approval for its CerusEndo MC 021 Mi...

Commercial Sales Across European Union Expected to Begin During Fourth Quarter of 2020

Silk Vista "Mama" 1st case experience

XCalibur AOD in treatment of direct carotid cavernous fistula